Navigation Links
Columbia researchers observe tunable quantum behavior in bilayer graphene
Date:7/10/2014

ed for the first time that varying the applied electric field causes a phase transition, but the exact nature of these different phases remains an open question. "While theory expects that we can tune the ground state order, the complexity of the system makes it difficult to determine exactly which order is actually realized," says Physics Professor and co-author Philip Kim.

"This is where the next phase of our research is headed," says Dean. "The implications for this result could be far reaching," he adds, "While we do not yet see any evidence of non-abelian states, the fact that we are able to modify the nature of the fractional quantum Hall effect by electric fields is a really exciting first step."

While previous efforts have been able to demonstrate different aspects of the sample requirement, no other group has been able to bring this all together into a single device. Dean attributes this success to the unique collaborative environment fostered at Columbia University. "This is truly a remarkable environment," he says, adding, "The open exchange of ideas across several disciplines makes the environment at Columbia a fertile ground for doing great science." Device fabrication and initial testing was done at Columbia University. Measurement under large magnetic fields was then performed by the Columbia team with the aid of the National High Magnetic Field Laboratory user facility in Tallahassee, Florida. "We have established a fantastic relationship with the NHFML over many years," says Dean. "The support provided by the NHMFL personnel at both the technical and scientific level has been invaluable to our efforts."


'/>"/>

Contact: Beth Kwon
byk2102@columbia.edu
212-854-6581
Columbia University
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Columbia Engineering wins $3 million ARPA-E grant to raise efficiency, lower cost of power grid
2. Columbia engineers make worlds smallest FM radio transmitter
3. Genia Technologies, Columbia University, and Harvard University Awarded $5.25 Million Grant from NIH to Accelerate the Development of NanoTag DNA Sequencing Technology
4. Dr. Szczepan Baran will be Presenting at the International Microsurgical Simulation Society at Columbia University in New York
5. Columbias Nursing School Launches "Keep It Clean for Kids" (KICK)
6. Worlds Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program
7. Researchers find that computer components can be damaged by key manufacturing processes
8. York U molecular communication researchers send worlds first text message using vodka
9. Researchers split water into hydrogen, oxygen using light, nanoparticles
10. CWRU engineering researchers report nanoscale energy-efficient switching devices at IEDM 2013
11. Berkeley Lab researchers create a nonlinear light-generating zero-index metamaterial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)...  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology ... announced that it will be presenting at CALBIO 2015 ... nd at 3pm PST. Patrick Lucy, chief business officer ... current state of the biosimilar industry landscape entitled ... For more information on CALBIO 2015 and The ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Cytokinetics, ... forces on February 28 with patients and health care ... awareness for Rare Disease Day®. Rare Disease Day ... and calling attention to the special challenges faced by ... them. , “Cytokinetics is proud to stand alongside patients ...
(Date:2/27/2015)... , Feb. 27, 2015   PureTech , a ... and commercializing disruptive products and technologies in the healthcare ... , former CEO and Member of the Board of ... "It,s has been a pleasure to know ... that we will be working together more closely now," ...
(Date:2/26/2015)... 26, 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured a ... Genewiz Inc. in excess of $10 million. The jury ... secrets, and that it improperly hired one or more ... motions for judgment notwithstanding the verdict, a new trial, ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
... and VANCOUVER, Feb. 4 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ... survival rate from a Phase 1/2 clinical trial of ... of advanced non-small cell lung cancer (NSCLC). At two ... first-line chemotherapy were alive. OncoGenex has previously reported a ...
... introduction to the benefits of Shape Memory Alloys. The Kit is a ... a comprehensive manual, and easy to follow demonstrations on the morphing abilities ... ... -- Imagine a future where the only tool in an auto body ...
... HUNTINGTON BEACH, California and AMSTERDAM, February 4 ... diagnostics, today announced that,its signature breast cancer ... of,care for all eligible early stage breast ... Leeuwenhoek Hospital (NKI-AVL). The NKI-AVL,believes MammaPrint provides ...
Cached Biology Technology:OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer 2OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer 3OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer 4OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer 5Re-Shaping the Future with Shape Memory Alloys - SMA Starter Kit 2Re-Shaping the Future with Shape Memory Alloys - SMA Starter Kit 3Agendia's Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL 2
(Date:2/5/2015)... TRIANGLE PARK, North Carolina , 5. ... sein 35. Jahr als spezialisiertes Logistikunternehmen und ... Position als einzige klinische Logistikfirma (Clinical Logistics ... Die Kernbotschaft der neuen Kampagne lautet ... und Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... SAN FRANCISCO , January 28, 2015 ... Camera Market Analysis, Size And Segment Forecasts To 2020 ... The global IR camera market is expected to reach ... study by Grand View Research, Inc. IR cameras help ... injuries, and are expected to witness surging demand in ...
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced ... Overview" report to their offering. , ... an individual is who she/he is claiming to be, and ... person,s unique physical characteristics, such as fingerprint, hand or palm ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... so indelibly that their children are affected. History ... starvation, whose children experience altered physiology. Now ... University have found an instance of animals passing ... to their offspring. That information comes not through ...
... mapping how proteins interact with each other, developed at ... the design of new drugs for diseases such as ... acids, the Salk scientists determine the detailed molecular structure ... that turns it on. The switch--corticotrophin releasing factor type ...
... 29 November 2013 The American Association for the Advancement ... Science Policy Programme at EMBO, to its 2013 class of ... upon AAAS members by their peers and acknowledges contributions that ... been recognized by AAAS for her work looking at the ...
Cached Biology News:Mice can inherit learned sensitivity to a smell 2Mice can inherit learned sensitivity to a smell 3Salk scientists crack riddle of important drug target 2Salk scientists crack riddle of important drug target 3
... The electrophoretic mobility shift assay (EMSA) ... interactions. Often referred to as gel shift ... on the principle that when subjected to ... a DNA-protein complex. The Pierce LightShift Chemiluminescent ...
... Lab Quantas unique combination of Coulter ... resolution capabilities and accurate cell counting. ... wavelengths, including UV, allowing flexible fluorochrome ... applications typically only achievable with larger, ...
... Genome-pULSe Kit delivers a novel procedure for ... labeling of whole genome DNA from small ... provide a quick and highly reproducible amplification ... consists of a REPLI-g Mini Kit module ...
... using PULSin may be superior to transfection ... traditional transfection, with PULSin you can study ... time course of proteins in cells. Likewise, ... information than traditional RNA interference experiments. ...
Biology Products: